Xori Gets $2.1M From Accelerator

Luke Timmerman5/15/09

The latest biotech startup from Seattle-based Accelerator, Xori, has received $2.1 million out of a $4.5 million financing round, according to a regulatory filing. The company (pronounced Chore-ee) is testing technology from the lab of Nancy Maizels at the University of Washington, which seeks to develop antibody drugs through a new technique in genetically modified chicken cells, as I described in this feature story yesterday.

Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.